The American Society of Clinical Oncology annual meeting, beginning this week in Atlanta, offers about as many sessions related to pharmacogenomics and targeted therapies as the 2005 meeting, with the exception of the developmental therapeutics track, which has approximately doubled the number of sessions in these areas to a total of six.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.